Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial-Reference-Cited by-同舟云学术

Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial

Published:1998-08 Issue:2 Volume:52 Page:195-202
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Andriole G.L.,Guess H.A.,Epstein J.I.,Wise H.,Kadmon D.,Crawford E.D.,Hudson P.,Jackson C.L.,Romas N.A.,Patterson L.,Cook T.J.,Waldstreicher J.

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Gormley GJ, Stoner E, Bruskewitz RC, et al, for the Finasteride Study Group: The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 327: 1185–1191, 1992.

2. The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia;Guess;Prostate,1993

3. Effect of finasteride on prostate-specific antigen density;Gormley;Urology,1994

4. The effect of finasteride on prostate specific antigen;Guess;J Urol,1996

5. Stoner E, for the Finasteride Study Group: Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. Arch Intern Med 154: 83–88, 1994.

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial Postoperative Prostate Specific Antigen and PSA Velocity Are Important Indicators of Underlying Malignancy After Simple Prostatectomy;Journal of Endourology;2023-09-01

2. An independent practice validation of the Prostate Imaging Reporting and Data System version 2 scoring system and the introduction of PDP (prostate-specific antigen density × PI-RADSv2) score to assist with further risk assessment;Current Urology;2022-08-31

3. Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality;JAMA Oncology;2022-07-01

4. The Impact of Lifestyle on Prostate Cancer: A Road to the Discovery of New Biomarkers;Journal of Clinical Medicine;2022-05-22

5. 5-Alpha Reductase Inhibitors and Prostate Cancer Mortality among Men with Regular Access to Screening and Health Care;Cancer Epidemiology, Biomarkers & Prevention;2022-03-04